Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-038989

Chief Operating Officer bought 10,000 shares at $1.05 ($10,500)

From the SEC's structured data for this filing

Trades in this filing

Dagnon Terry · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-06-21 Purchase : show line 1 in the form +10,000 $1.05 $10,500 1,173,058 D
Open-market purchases · 10,000 sh · avg $1.05 · $10,500
Loading xslF345X03/doc4.xml…